AVEO Pharmaceuticals Inc

NASDAQ:AVEO   9:51:07 AM EDT
6.96
+0.22 (+3.19%)
Earnings Announcements

Aveo Oncology Reports Full Year 2020 Financial Results

Published: 03/16/2021 22:11 GMT
AVEO Pharmaceuticals Inc (AVEO) - Aveo Oncology Reports Full Year 2020 Financial Results and Provides Business Update.
Revenue is expected to be $1.35 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $9.1 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.